Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects

Zhi Bing You, Guo Hua Bi, Ewa Galaj, Vivek Kumar, Jianjing Cao, Alexandra Gadiano, Rana Rais, Barbara S. Slusher, Eliot L. Gardner, Zheng Xiong Xi, Amy Hauck Newman

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects'. Together they form a unique fingerprint.

Medicine & Life Sciences